BioTuesdays: HDT Bio focused on global impact of mRNA vaccine platform May 23, 2023 | In the NewsClick here to view...
Empowered Patient Podcast: Advanced RNA Technology Cost-Effectively Creating mRNA Vaccines for Viruses and Cancer with Steve Reed HDT Bio Apr 25, 2023 | In the NewsClick here to view...
Fierce Biotech: HDT Bio’s Zika and HIV vaccines generate immune responses in pregnant rabbits and their offspring Mar 27, 2023 | In the NewsClick here to view...
GeekWire: Seattle Startup HDT Bio Lands $1.8M U.S. Army Grant to Develop Nasal Spray Against Viruses Aug 11, 2022 | In the NewsClick here to view...
Public Library of Science: And Then There Were 33…The Latest 11 COVID Vaccines to Reach the Phase 3 Results Milestone Aug 5, 2022 | In the NewsClick here to view...
Pharmaceutical Technology: HDT Bio Receives Emergency Use Approval for Covid-19 Vaccine in India Jun 30, 2022 | In the NewsClick here to view...
